RU95106650A -
PHARMACEUTICAL COMPOSITIONS FOR PREVENTING THE FORMATION OF CANCER METASTASES IN THE LIVER AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LIVER CANCER
- Google Patents
PHARMACEUTICAL COMPOSITIONS FOR PREVENTING THE FORMATION OF CANCER METASTASES IN THE LIVER AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LIVER CANCER
Info
Publication number
RU95106650A
RU95106650ARU95106650/14ARU95106650ARU95106650ARU 95106650 ARU95106650 ARU 95106650ARU 95106650/14 ARU95106650/14 ARU 95106650/14ARU 95106650 ARU95106650 ARU 95106650ARU 95106650 ARU95106650 ARU 95106650A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ниппон Каяку Кабусики КайсяfiledCriticalНиппон Каяку Кабусики Кайся
Publication of RU95106650ApublicationCriticalpatent/RU95106650A/en
1. Фармацевтическая композиция для предотвращения образования метастазов рака печени для лечения рака печени, включающая в качестве активного начала эффективное количество цитарабин окфосфата формулы I
2. Способ предотвращения образования метастазов рака в печени и лечения рака печени, отличающийся тем, что включает введение эффективной дозы цитарабин окфосфата формулы I.1. A pharmaceutical composition for preventing the formation of liver cancer metastases for the treatment of liver cancer, comprising, as an active principle, an effective amount of cytarabine oxphosphate of the formula I
2. A method of preventing the formation of cancer metastases in the liver and the treatment of liver cancer, characterized in that it includes the introduction of an effective dose of cytarabine oxphosphate of the formula I. 3. Применение цитарабин окфосфата для получения фармацевтической композиции для предотвращения образования метастазов рака в печени и для лечения рака печени, включающей в качестве эффективного ингредиента цитарабин окфосфат формулы I. 3. The use of cytarabine oxphosphate to obtain a pharmaceutical composition for preventing the formation of cancer metastases in the liver and for the treatment of liver cancer, comprising, as an effective ingredient, cytarabine oxphosphate of formula I. 4. Способ получения фармацевтической композиции для предотвращения образования метастазов рака в печени и для лечения рака печени, отличающийся тем, что включает смешивание цитарабин окфосфата в качестве активного ингредиента с наполнителем или носителем. 4. A method of obtaining a pharmaceutical composition for preventing the formation of cancer metastases in the liver and for treating liver cancer, characterized in that it comprises mixing cytarabine ophosphate as an active ingredient with an excipient or carrier.
RU95106650/14A1992-08-101993-08-05
PHARMACEUTICAL COMPOSITIONS FOR PREVENTING THE FORMATION OF CANCER METASTASES IN THE LIVER AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LIVER CANCER
RU95106650A
(en)
1-CARBOXYALKANOYLINDOLINE-2-CARBONIC ACIDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
PROCESS TO PREPARE A BIFUNCTIONAL CHELANT, PROCESS TO PREPARE A COMPLEX OF A COMPOUND, PROCESS TO PREPARE A CONJUGATE AND PROCESS TO PREPARE A PHARMACEUTICAL FORMULATION
Bis-naphthalimide-type compound pharmaceutical composition process for treating a mammalian tumor use of bis-naphthalimide-type compound and process for the preparation of bis-naphthalimide-type compounds
New adenosine derivatives, methods of their synthesis, pharmaceutical compositions based on thereof, methods of preparing pharmaceutical compositions and their use
PHARMACEUTICAL COMPOSITIONS FOR PREVENTING THE FORMATION OF CANCER METASTASES IN THE LIVER AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LIVER CANCER
